Page last updated: 2024-10-23

bethanechol and Barrett Epithelium

bethanechol has been researched along with Barrett Epithelium in 5 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Research Excerpts

ExcerptRelevanceReference
"Gastroesophageal reflux (GER) disease is a common, multifactorial medical condition that may be difficult to treat."1.27A critical review of current medical therapy for gastroesophageal reflux disease. ( Richter, JE, 1986)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, LS1
Vegesna, AK1
Braverman, AS1
Barbe, MF1
Ruggieri, MR1
Heading, RC1
Baldi, F1
Holloway, RH1
Janssens, J1
Jian, R1
McCallum, RW1
Richter, JE2
Scarpignato, C1
Sontag, SJ1
Wienbeck, M1
Spechler, SJ1
Goyal, RK1
Humphries, TJ1

Reviews

1 review available for bethanechol and Barrett Epithelium

ArticleYear
Barrett's esophagus.
    The New England journal of medicine, 1986, Aug-07, Volume: 315, Issue:6

    Topics: Adenocarcinoma; Antacids; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Epithel

1986

Other Studies

4 other studies available for bethanechol and Barrett Epithelium

ArticleYear
Enhanced nicotinic receptor mediated relaxations in gastroesophageal muscle fibers from Barrett's esophagus patients.
    Neurogastroenterology and motility, 2014, Volume: 26, Issue:3

    Topics: Adult; Barrett Esophagus; Bethanechol; Carbachol; Cholinergic Agonists; Esophagus; Female; Humans; M

2014
Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996.
    European journal of gastroenterology & hepatology, 1998, Volume: 10, Issue:1

    Topics: Barrett Esophagus; Bethanechol; Cisapride; Gastric Emptying; Gastroesophageal Reflux; Gastrointestin

1998
A critical review of current medical therapy for gastroesophageal reflux disease.
    Journal of clinical gastroenterology, 1986, Volume: 8 Suppl 1

    Topics: Alginates; Antacids; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Gastroesopha

1986
Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.
    Journal of clinical gastroenterology, 1987, Volume: 9, Issue:1

    Topics: Adult; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Esophageal Diseases; Esoph

1987